Related by context. All words. (Click for frequent words.) 71 affective disorders 71 affective psychosis 70 euthymic 69 probands 68 euthymic patients 68 comorbid depression 68 comorbid anxiety 67 proband 67 schizophrenia schizoaffective disorder 67 nondepressed 67 comorbid disorders 67 depressive symptomatology 66 suicide attempters 65 Suicidal ideation 65 dysthymia 65 shorter telomere length 65 unipolar depression 65 meta analytic review 65 GH deficiency 65 affective psychoses 65 neuroleptic 65 nondemented 65 nonpsychiatric 65 schizophreniform disorder 65 subsyndromal 65 affective disorder 65 clomipramine 64 sociodemographic characteristics 64 venlafaxine XR 64 generalized anxiety disorder GAD 64 psychiatric comorbidities 64 comorbid 64 opioid dependent 64 #q# deletion syndrome 64 premorbid 64 neurocognitive impairment 64 hypochondriasis 63 chronicity 63 psychiatric comorbidity 63 convulsive disorders 63 familial aggregation 63 neurocognitive functioning 63 comorbid ADHD 63 psychosocial functioning 63 sedatives hypnotics 63 multivariate analyzes 63 symptom severity 63 somatoform disorders 63 VaD 63 bivariate analyzes 63 quetiapine risperidone 63 psychiatric morbidity 63 euthyroid 63 T2DM 62 risperidone Risperdal 62 hyper IgE syndrome 62 neuroleptic drugs 62 schizotypal 62 Comorbid 62 comorbid psychiatric 62 tryptophan depletion 62 retrospective cohort 62 haematologic 62 Cognitive behavioral 62 antidepressants fluoxetine 62 Atypical antipsychotics 62 alexithymia 62 dysthymic disorder 62 fluoxetine paroxetine 62 somatic symptoms 62 IPAH 62 Heritability 62 psychoeducation 62 quetiapine Seroquel 62 pediatric bipolar disorder 62 D Cycloserine 62 HIV HCV coinfected 62 puerperal psychosis 62 venlafaxine Effexor 62 T1DM 62 confusional 62 MMSE score 62 hypoactive 62 DSM IV diagnosis 62 psychiatric disorders ATI 61 syndromal 61 % CI #.#-#.# [008] 61 bulimia nervosa 61 mild renal insufficiency 61 poststroke 61 Antisocial Personality Disorder 61 monozygotic twin 61 psychiatric outpatients 61 interpersonal psychotherapy 61 somatization disorder 61 SSRI citalopram 61 schizotypal personality disorder 61 somatoform disorder 61 hippocampal volumes 61 overactive bladder symptoms 61 logistic regression analysis 61 chlorpromazine 61 amisulpride 61 postintervention 61 parkinsonian 61 sociodemographic variables 61 interpersonal psychotherapy IPT 61 paroxetine sertraline 61 Comorbidity 61 mania hypomania 61 dyads 61 meta regression 61 diabetes mellitus DM 61 idiopathic PAH 61 Socio demographic 61 opioid naive 60 sensory gating 60 lowest tertile 60 Exclusion criteria 60 Fluvoxamine 60 % CI #.#-#.# [003] 60 ziprasidone 60 antiepileptics 60 schizophrenia 60 acute mania 60 STEP BD 60 lipid lowering agents 60 neuroleptics 60 recurrent acute pancreatitis 60 CC genotype 60 Electroconvulsive therapy 60 neuropsychological functioning 60 Generalized Anxiety Disorder 60 Sociodemographic 60 Major Depressive Disorder 60 comorbid psychiatric disorders 60 serum estradiol 60 neuropsychiatric symptoms 60 guideline concordant 60 citalopram Celexa 60 relapsed MM 60 Schizoaffective Disorder 60 QIDS SR 60 Atomoxetine 60 MMSE scores 60 EFFEXOR XR 60 neurocognitive function 60 psychophysiological 60 comorbid substance 60 fluvoxamine 60 Helicobacter pylori eradication 60 tricyclic antidepressant 60 serotonin norepinephrine 60 Y BOCS 60 attain statistical significance 60 hypersomnia 60 schizophrenic bipolar 60 citalopram 60 methotrexate monotherapy 60 subthreshold 60 antiretroviral naïve 60 cognitively intact 60 cirrhotic 60 bipolar disorders 60 psychotic disorders 60 TEAEs 60 HeFH 60 haloperidol Haldol 60 GABRA2 60 autosomal dominant inheritance 60 Pavuluri 60 psychiatric diagnoses 60 pretransplant 60 nondiabetic patients 60 psychotherapeutic drugs 60 serotonin reuptake inhibitors 60 comorbid diagnoses 60 hyperprolactinemia 60 major depressive disorder 60 Depressive symptoms 59 depression suicidal ideation 59 induced akathisia 59 adenoidectomy 59 #q#.# deletion syndrome 59 divalproex 59 hyperreflexia 59 dementia praecox 59 unmedicated 59 SSRI SNRI 59 p = .# [002] 59 Obsessive compulsive disorder OCD 59 Selective serotonin reuptake inhibitors 59 internalizing disorders 59 hypomanic episodes 59 tipranavir ritonavir 59 headache abdominal pain 59 Attention-Deficit/Hyperactivity Disorder ADHD 59 olanzapine quetiapine 59 adjunctive placebo 59 tranylcypromine 59 antiseizure drug 59 Imipramine 59 #q# deletion 59 somatization 59 monoamine oxidase inhibitors 59 nonobese 59 extrapyramidal symptoms 59 HIV lipodystrophy 59 atypical neuroleptics 59 prospectively enrolled 59 elevated ALT 59 Montgomery Åsberg Depression 59 acarbose 59 neurocognitive dysfunction 59 paranoid ideation 59 ADHD stimulant 59 autonomic dysfunction 59 Cognitive impairment 59 prescribed antipsychotic medication 59 migraine prophylaxis 59 Posttraumatic stress disorder 59 RLAI 59 hemodynamically significant 59 de novo AML 59 Abilify aripiprazole 59 salivary cortisol 59 bipolar illness 59 mu opioid 59 nortriptyline Pamelor 59 schizophreniform 59 prodromal 59 electrophysiologic 59 Carbamazepine 59 DSM IV Axis 59 concomitant AEDs 59 amnestic 59 amnestic MCI 59 Bipolar Mania 59 attention-deficit/hyperactivity disorder 59 Pharmacologic 59 receiving ISENTRESS 59 cerebral oxygenation 59 neuropsychological deficits 59 univariate analyzes 59 multivariable analysis 59 opioid naïve 59 confidence interval #.#-#.# 59 recurrent glioblastoma multiforme 59 dopamine antagonists 59 nonepileptic seizures 59 metaanalysis 59 comorbidity 59 nondiabetic 58 primary hypercholesterolemia 58 hepatic enzyme 58 hematopoietic cancers 58 dalteparin 58 fluoxetine Prozac 58 borderline personality disorders 58 moderate hepatic impairment 58 corticosteroid dose 58 antimuscarinic 58 INVEGA ® 58 TT genotype 58 sub syndromal 58 APOE genotype 58 experimental allergic encephalomyelitis 58 Parnate 58 externalizing disorders 58 conditional logistic regression 58 Personality disorders 58 psychopharmacological 58 diagnosing ADHD 58 paroxysmal AF 58 pyridostigmine 58 hypomanic symptoms 58 manic hypomanic 58 adjunctive ABILIFY 58 underwent liver transplantation 58 eszopiclone 58 thyroid carcinoma 58 induce orthostatic hypotension 58 null responder 58 Mood disorders 58 Symptom severity 58 Suicidal thoughts 58 Heterozygous Familial Hypercholesterolemia 58 acute bipolar mania 58 nonadherence 58 sertraline Zoloft 58 heterozygous familial 58 premenstrual dysphoric disorder 58 PsA 58 ziconotide 58 dissociative disorders 58 dysphoric 58 undergone radical prostatectomy 58 terazosin 58 left ventricular diastolic 58 imipramine Tofranil 58 gastroesophageal reflux GERD 58 HIV uninfected 58 electroencephalographic 58 neurological abnormalities 58 comorbid conditions 58 oral antidiabetes drugs 58 thyrotoxicosis 58 divalproex sodium 58 prolactin elevation 58 tricyclic antidepressants TCAs 58 Flu Cy 58 Antidepressant medications 58 ego dystonic 58 ß blockers 58 Adjunctive 58 antiandrogen 58 underwent resection 58 neurodevelopmental impairment 58 multiple logistic regression 58 thrombophilia 58 C1 INH deficiency 58 CORE OM 58 generalized tonic clonic seizures 58 imipramine 58 logistic regression model 58 dexmedetomidine 58 subscale scores 58 rufinamide 58 impaired cognition 58 hepatic encephalopathy HE 58 desvenlafaxine succinate 58 underwent CABG 58 idiopathic generalized epilepsy 58 pooled comparator 58 irregular menses 58 inhaled bronchodilators 58 salmeterol fluticasone 58 BMI z 58 pain catastrophizing 58 autopsied brains 58 sociodemographic factors 58 Intravenous immunoglobulin 58 odds ratios ORs 58 posttransplant 58 antirheumatic 58 moderate renal impairment 57 antiretroviral naive 57 body dysmorphic disorder 57 dysthymic 57 Parkinson Disease PD 57 decompensated cirrhosis 57 perimenopausal women 57 abacavir lamivudine 57 serum urate levels 57 hsCRP levels 57 paroxetine Paxil 57 Baseline characteristics 57 5 HTTLPR 57 Neuropsychiatric Inventory NPI 57 bullous 57 choroidal vasculopathy 57 advanced neoplasia 57 hyperkinetic disorder 57 anxiolytic 57 sd = 57 treating neuropathic pain 57 Social Phobia 57 flutamide 57 covariate 57 Zoloft sertraline 57 Nicotine dependence 57 Interpersonal psychotherapy 57 leukocyte counts 57 pentoxifylline 57 Pain Rating Scale 57 bipolar affective disorder 57 lipid altering 57 efavirenz EFV 57 obstructive sleep 57 buprenorphine implants 57 vWD 57 NATRECOR ® 57 GBA mutations 57 mg BID dose 57 IOP lowering 57 parkinson disease 57 osteopenic 57 osteosarcomas 57 hyperarousal 57 Oppositional Defiant Disorder 57 normal karyotype 57 sotalol 57 operable breast cancer 57 postoperative delirium 57 attention-deficit/hyperactivity disorder ADHD 57 psychopathological 57 symptomatic BPH 57 neuropsychiatric disorder 57 liver metastasis 57 histologic subtype 57 tonsillar hypertrophy 57 antiphospholipid antibodies 57 Multivariate analyzes 57 serum folate concentrations 57 PEGINTRON TM 57 decompensated liver disease 57 ABCB1 57 multivariate adjustment 57 Juvenile Idiopathic Arthritis 57 neuropsychological impairment 57 oxycodone CR 57 Cognitive dysfunction 57 nontraumatic 57 prospectively stratified 57 Intervention Effectiveness 57 saline infusion 57 allele frequencies 57 buspirone 57 multi infarct dementia 57 decompensated 57 Research www. elsevier.com 57 cryptogenic 57 posttreatment 57 suicide ideation 57 nonpharmacological 57 conventional DMARDs 57 neurosensory 57 bipolar depression 57 CANCIDAS 57 mutated K ras 57 depressive symptom 57 monozygotic 57 plasma creatinine 57 atrophic gastritis 57 chronic renal insufficiency 57 tumor subtype 57 posterior cingulate 57 OSAHS 57 ziprasidone Geodon 57 hMG 57 methylphenidate Ritalin 57 MIRAPEX 57 deep venous thromboses 57 Escitalopram 57 pramipexole Mirapex 57 HRQOL 57 psychoactive medications 57 postoperative AF 57 antiarrhythmic drug 57 dyslipidemic 57 oxcarbazepine 57 AGILECT R 57 Structured Clinical 57 pregabalin Lyrica 57 Subgroup analysis 57 prescribed antipsychotics 57 aripiprazole 57 clinicopathological 57 symptomatology 57 isolated systolic hypertension 57 serotonin reuptake inhibitor 57 suicidal ideation 57 immunocompetent 57 extrapyramidal disorder 57 emotional lability 57 Akathisia 57 multivariable adjusted 57 dyslipidaemia 57 rCBF 57 clinicopathological features 57 suboptimal adherence 57 postdischarge 57 abacavir Ziagen 57 typical antipsychotics 57 ragweed allergic 57 prefrontal cortical 57 beta carotene supplementation 57 % CI #.#-#.# [007] 57 Pathologic 57 carotid IMT 57 poor metabolizers 57 metaplasia 57 CYP#D# inhibitor 57 normotensive 57 poststroke depression 57 pharmacologic treatments 57 BPS IC 57 GH deficient 57 nonautistic 57 proton MR spectroscopy 57 lymphocyte count 57 eosinophilic asthma 57 chronic noncancer pain 57 parkinsonian symptoms 57 Lewy bodies DLB 57 anticholinergic agents 57 TMP SMX 57 prostate cancer CaP 57 hippocampal volume 57 DSM IV criteria 57 nonmetastatic 57 diarrhea predominant IBS 57 anagrelide 57 EEG abnormalities 57 Clinical Antipsychotic Trials 57 syndromic 57 subclinical disease 57 df = 57 oral hypoglycemic 57 prodromal symptoms 56 ADCS CGIC 56 DQB1 * 56 thyrotropin levels 56 neurocognition 56 psychopharmacologic 56 premenstrual syndrome PMS 56 constipation predominant IBS 56 pharmacokinetic interactions 56 Lamotrigine 56 manic depression bipolar disorder 56 intravenous cyclophosphamide 56 complement inhibitor eculizumab 56 psychosocial variables 56 neuropsychological impairments 56 impaired glucose metabolism 56 overactive bladder syndrome 56 hyperphenylalaninemia HPA due 56 SSRI antidepressant 56 left ventricular systolic 56 neurologic abnormalities 56 Duloxetine 56 clinico pathological 56 dysfunctional voiding 56 systolic dysfunction 56 antiandrogens 56 urolithiasis 56 tumor histology 56 virological response 56 Neuropsychological 56 tricyclic antidepressants 56 untreated psychosis 56 undergoing coronary angiography 56 titrated glipizide 56 patientswith 56 DAS# CRP 56 vesicoureteral reflux 56 Zeldox 56 aged ≥ 56 postinjury 56 psychopathology 56 abstinent alcoholics 56 IBS C 56 non affective psychosis 56 Univariate 56 psychotic illnesses 56 differential gene expression 56 Protease inhibitor 56 anxiolytics 56 nociceptive pain 56 generalized epilepsy 56 schizophrenics 56 hepatic insufficiency 56 Effexor venlafaxine 56 hamartomas 56 parasomnias 56 Psychotropic medications 56 nortriptyline 56 primary aldosteronism 56 neuropsychological assessments 56 onset seizures 56 sustained ventricular tachycardia 56 nonadherent 56 Index CDAI 56 cognitive affective 56 highest tertile 56 hypokalemia hypomagnesemia 56 Wernicke Korsakoff syndrome 56 Borderline personality 56 tolterodine ER 56 β blockers 56 clobazam 56 intracranial stenosis 56 hypercholesterolemic 56 Paliperidone ER 56 #mg/day [001] 56 elevated LDH 56 MADRS score 56 aspirin clopidogrel 56 noncancer pain 56 sociodemographic 56 oxycodone IR 56 psychostimulants 56 bipolar disorder schizophrenia 56 hypogonadotropic hypogonadism 56 serum bicarbonate 56 somatic complaints 56 CP CPPS 56 practitioners internists 56 psychiatric inpatients 56 Primary endpoints 56 subclinical hypothyroidism 56 receiving XGEVA 56 bivariate 56 cognitively normal 56 mirtazapine Remeron 56 androgen excess 56 lacunar 56 generalized estimating 56 genotypic resistance 56 familial pancreatic cancer 56 hypertension diabetes mellitus 56 Neuroticism 56 retrospectively analyzed 56 State Exam MMSE 56 torsade de pointes 56 familial clustering 56 Scale PANSS 56 DPNP 56 medically refractory 56 psychiatric disorders 56 Chronic ITP 56 prevalences 56 Mental Disorders DSM IV 56 agomelatine 56 rheumatologic 56 nulliparous women 56 nonalcoholic steatohepatitis NASH 56 extracellular dopamine 56 investigational atypical antipsychotic 56 HIV coinfected 56 serum PTH 56 antiarrhythmic medications 56 EQ 5D 56 confidence intervals CIs 56 bispectral index BIS 56 habitual snoring 56 prospectively defined 56 urinary cortisol 56 psychomotor agitation 56 cervicitis 56 atherothrombotic 56 Paxil paroxetine 56 baseline HbA1c 56 MetS 56 salmeterol HFA MDI 56 Generalised Anxiety Disorder 56 urinary N telopeptide 56 idiopathic Parkinson disease 56 atypical hemolytic uremic syndrome 56 mirtazapine 56 generalized anxiety disorder 56 prospective nonrandomized 56 Framingham Offspring 56 tolterodine 56 catechol O methyltransferase 56 HRQoL 56 5 HTTLPR genotype 56 autoimmune thyroid 56 chest radiographs 56 thiazide diuretic 56 galiximab 56 Genetic susceptibility 56 diabetes mellitus hypertension 56 lumbar disc disease 56 dexmethylphenidate 56 inhaled budesonide 56 histologically proven 56 anorexia nervosa bulimia 56 hypoperfusion 56 delusions hallucinations 56 juvenile idiopathic arthritis JIA 56 depression suicidality 56 subthreshold depression 56 serum BDNF 56 PSA nadir 56 HBeAg negative patients 56 propranolol Inderal 56 polytherapy 56 certolizumab 56 systolic hypertension 56 elevated creatinine 56 sacral nerve stimulation 56 partial onset seizures 56 Vidaza ® 56 biliary tract cancer 56 Relapsing remitting MS 56 CTEPH 56 Haloperidol 56 CI #.#-#.# [001] 56 proliferative retinopathy 56 K ras mutations 56 behavioral disinhibition 56 haematological 56 Major Depressive Disorder MDD 56 inotropic agents 56 pharmacotherapeutic 56 hippocampal atrophy 56 warfarin erythromycin 56 norepinephrine reuptake inhibitor 56 oral prednisolone 56 serotonergic 56 plasma pharmacokinetics 56 deletion 5q 56 neuropathologic 56 CIMZIA TM certolizumab pegol 56 AChE inhibitors 56 Postoperative complications 56 Buspirone 56 antiplatelet medications 56 nonischemic 56 pulmonary dysfunction 56 leptin deficiency 56 ictal 56 UPDRS 56 comorbid illnesses 56 biopsychosocial 55 EoE 55 Prefrontal 55 unfavorable cytogenetics 55 cranial irradiation 55 albumin excretion 55 PLX STROKE targeting 55 Pathological gambling 55 psychiatric hospitalization 55 Antipsychotic 55 prolonged QT intervals 55 diabetic neuropathic pain 55 % Confidence Interval 55 nocturnal enuresis 55 norepinephrine reuptake inhibitor SNRI 55 Schizophrenics 55 prostatic hyperplasia 55 lorazepam Ativan 55 hyperalgesia 55 NPH insulin 55 nicardipine 55 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 55 Poisson regression 55 dopaminergic therapy 55 glycated hemoglobin levels 55 Anxiety disorders 55 Univariate analysis 55 SGPT 55 thetreatment 55 logistic regression analyzes 55 paclitaxel eluting stents 55 SGAs 55 8mg/kg 55 atopic asthma 55 Relieve Depression 55 dopamine D2 receptor 55 lamivudine resistant 55 decompensated heart failure 55 LRRK2 mutation 55 papillary renal cell carcinoma 55 ECOG PS 55 substance induced psychosis 55 coinfected 55 schizophrenia bipolar 55 hyperlipidaemia 55 Sjögren syndrome 55 tiagabine 55 borderline personality disorder 55 hypercholesterolaemia 55 Major depressive disorder 55 nonpharmacologic 55 lesional 55 sertraline 55 tegaserod 55 aortic atherosclerosis 55 COPD exacerbation 55 L thyroxine 55 hyperammonemia 55 Diagnostic Criteria 55 impaired renal 55 mild renal impairment 55 overnight polysomnography 55 statistically significant predictor 55 paroxetine Seroxat 55 narcolepsy cataplexy 55 timepoints 55 β blocker 55 SSc 55 subclinical atherosclerosis 55 nonfatal MI 55 guanfacine extended release 55 baseline LDH 55 schizoaffective disorders 55 carcinomatosis 55 disorder FSAD 55 HAM D# 55 inattention hyperactivity 55 juvenile idiopathic arthritis 55 limiting generalizability 55 clinicopathologic 55 varenicline Chantix 55 prolactin levels 55 underwent coronary angiography 55 hepatocellular carcinomas 55 levetiracetam 55 colorectal adenomas 55 DAS# scores 55 Subgroup analyzes 55 noncardiac 55 clozapine Clozaril 55 schizophrenia bipolar disorders 55 antihyperglycemic 55 alfuzosin 55 atopic disorders 55 coronary microvascular 55 tipranavir r 55 electroconvulsive therapy ECT 55 prognostic indicators 55 noncardiovascular mortality 55 lipid lowering medications 55 aripiprazole Abilify 55 mixed hyperlipidemia 55 locomotor activity 55 colorectal adenoma 55 Tricyclic antidepressants 55 lysosomal storage disease 55 donepezil Aricept 55 impulsivity characteristic 55 male Wistar rats 55 schizoaffective disorder 55 VADT 55 variceal bleeding 55 KRAS mutations occur 55 cardiotoxic 55 serum lipid levels 55 Quetiapine 55 ischemic cardiomyopathy 55 Chronic Heart Failure 55 Dementia Related Psychosis 55 Psychiatric disorders 55 familial hypercholesterolemia 55 bronchial hyperresponsiveness 55 achieved statistical significance 55 nonhereditary 55 polygenic 55 schizoaffective 55 nocturnal hypoglycemia 55 Brodmann Area 55 akathisia 55 constipation OIC 55 hypogonadal men 55 LV dysfunction 55 QoL 55 manufactures VIVITROL ® 55 recurrent tonsillitis 55 preintervention 55 depressive symptoms 55 preserved systolic 55 psoriatic arthritis PsA 55 GG genotype 55 LHRH agonists 55 depression schizophrenia bipolar 55 rs# [004] 55 insulin detemir 55 maximally tolerated lipid lowering 55 Comorbidities 55 DRD2 55 arterial thickening 55 Excessive daytime sleepiness 55 SRBD 55 extramedullary 55 rimonabant #mg 55 systemic corticosteroid 55 bronchoalveolar lavage fluid 55 gonadotrophin releasing hormone 55 preoperative PSA 55 atrioventricular block 55 thiopurine 55 DSM IV TR 55 escitalopram Lexapro 55 potential confounding variables 55 BPH LUTS 55 olanzapine LAI 55 RISPERDAL ® 55 Fasting plasma glucose 55 abnormal cytology 55 Posttraumatic 55 anticonvulsant medications 55 conducted retrospective cohort 55 radicular pain 55 postnatally 55 coadministration 55 Non inferiority 55 prognostic variables 55 plasma homocysteine levels 55 Ziprasidone 55 oral antidiabetes 55 lymphomas leukemias 55 underactive thyroids 55 antidepressants SSRIs 55 abnormal lipid 55 fluvoxamine Luvox 55 perseverative 55 vasoactive 55 psychometric properties 55 TMC# r 55 perioperatively 55 histological subtype 55 aneurysmal subarachnoid hemorrhage 55 HLA DR4 55 nonexposed 55 TF CBT 55 prescribed psychotropic drugs 55 Insulin sensitivity 55 hypercoagulable 55 % CI #.#-#.# [006] 55 schizophrenia bipolar disorder 55 avoidant personality disorder 55 obsessive compulsive disorder OCD 55 acromegalic patients 55 Adjuvant therapy 55 dysmenorrhoea 55 endogenous opioid 55 cerebral microbleeds 55 ALI ARDS 55 Suicidal behavior 55 RezularTM 55 genotype phenotype 55 erection hardness 55 doxazosin 55 retrospective cohort study 55 cerebral atrophy 55 lamotrigine 55 hippocampal function 55 anticonvulsant medication 55 somnolence dizziness 55 progranulin mutations 55 antidepressants antipsychotics 55 GABRA2 gene 55 prospective longitudinal 55 rhinoconjunctivitis 55 multivariate logistic regression 55 primidone 55 coinfected patients 55 Intervention Effectiveness CATIE 55 Psychosomatic Research 55 aldosterone antagonists 55 NMIBC 55 INVEGA SUSTENNA 55 headache nasopharyngitis 55 chronic obstructive airway 55 naïve HCV 55 fractional anisotropy 55 polyarticular 55 Attention Deficit Hyperactive Disorder 55 androgen deficiency 55 Pamelor 55 TPV r 55 primary dysmenorrhoea 55 HBeAg negative 55 autistic traits 55 revascularizations 55 Sydenham chorea 55 psychotropics 55 Clinical Psychiatry 55 plasma homocysteine 55 intravenous morphine 55 PREZISTA ritonavir 55 KCNH2 55 congenital deficiency 55 Hurthle cell 55 pheochromocytoma 55 atopic 55 Valium diazepam 55 acute myeloid 55 univariate analysis 55 akinetic mutism 54 myoclonus 54 neuroanatomical 54 nonmedically 54 Alequel 54 HBeAg positive 54 BRCA1 BRCA2 54 histologically confirmed 54 antipsychotic prescribing 54 pT3 54 myeloproliferative neoplasms 54 bipolar mania 54 monogenic 54 chronic neuropathic pain 54 autoimmune thyroiditis 54 Rating Scale MADRS 54 manic depressive illness 54 seropositivity 54 Suicidality 54 severe mitral regurgitation 54 pregabalin 54 periprocedural 54 Angiotensin receptor blockers 54 Ménière disease 54 POAG 54 ropinirole Requip 54 CONCERTA ® 54 overt hypothyroidism